Citrini Research Backs Life Sciences Stocks After Using Claude to Design Proteins
The firm designed 211 proteins with the AI model for lab testing, finding that 17 bound to scorpion toxins.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
First reported by Quartz, 3h 47m ahead of the next publisher · who breaks stories first
This story has stopped developing; this page is its permanent record. More from that day
The story so far
3 publishers have covered this in 4 articles since 20 Oct 2026. Quartz published first, on 20 October at 14:01 UTC; Hacker News followed 3h 47m later. The most recent article, from The Verge, appeared on 22 October at 12:21 UTC.
Outlets reporting it: The Verge (major outlet), Quartz, Hacker News.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
- QuartzCitrini Research is backing life sciences stocks after using Claude to design proteins
- QuartzCitrini Research unterstützt Aktien im Bereich der Lebenswissenschaften, nachdem Claude verwendet wurde, um Proteine zu gestalten.
- Hacker NewsClaude designed protein binders against scorpion neurotoxins
- The VergeClaude did not invent scorpion antivenom
Sources
Every article we clustered into this story. Headlines link to the publisher.
- Claude did not invent scorpion antivenom The Verge ·
- Citrini Research unterstützt Aktien im Bereich der Lebenswissenschaften, nachdem Claude verwendet wurde, um Proteine zu gestalten. Quartz
- Citrini Research is backing life sciences stocks after using Claude to design proteins Quartz
- Claude designed protein binders against scorpion neurotoxins Hacker News
In this story
- Citrini Research
- Claude